Table 3

Additional Outcomes at 2 Years

TAVR GroupSurgical Groupp Value
Reintervention9 (2.5)1 (0.4)0.02
Surgical3 (0.8)1 (0.4)0.38
Percutaneous6 (1.7)00.02
Valve endocarditis3 (0.9)5 (1.7)0.35
Valve thrombosis00
Valve embolism or migration00
Aortic valve hospitalization85 (24.2)56 (18.2)0.08

Values are n (%). All data reported as Kaplan-Meier estimates at the specific time point and do not equal the number of patients with events divided by the total number of patients in each treatment group. p values were calculated by using the log-rank test for all data through 2 years.

Abbreviations as in Table 1.